Clinical Trial

METABolic Deterioration in HTX Determines Outcomes

Name: METABolic Deterioration in HTX Determines Outcomes — clinical trial record (NCT07372820)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: METAB-HTX

Recruiting

View on ClinicalTrials.gov →

Summary

METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.

Trial Details

NCT Number	NCT07372820
Lead Sponsor	Heinrich-Heine University, Duesseldorf
Conditions	Heart Transplantation
Enrollment	270 participants
Start Date	2025-07-24
Primary Completion	2030-04-01 (estimated)
Study Completion	2032-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-01-28